In addition, in support of the theme of improvement in operational performance, CTI has been able to ramp recent revenue with very little increase in operating expenses. And we see no reason why this trend will not continue. On the earnings call management noted that they expect to have several announcements in the coming weeks related to a GSA agreement as well as details related to the previously proposed pivotal clinical study.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.